Imlygic
Active substance: talimogene laherparepvec
INJECTION, SUSPENSION · TALIMOGENE LAHERPAREPVEC 1000000 [PFU]/mL
United StatesActive
Marketing holder: Amgen Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TALIMOGENE LAHERPAREPVEC · 1000000 [PFU]/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-ed4c-7eae-b1cb-31e967647357,01a12098-d02f-786e-ba00-9754907bc8d4;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-078
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRALESIONAL
Sources
- product · openFDA NDC · 55513-078 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-078 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-078 · Verified 2026-10-09 · open in source